AdaptHealth Corp. (AHCO) vs Pacific Biosciences of California, Inc. (PACB)

A side-by-side comparison of AdaptHealth Corp. and Pacific Biosciences of California, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AHCO vs PACB

growth of $100 · dividends reinvested · last 8y
AHCO -40.8% (-6.3%/yr)PACB +9.1% (+1.1%/yr)PACB compounded faster over this window
05001k2k2kStart $1002020202220242026$59$109
AHCO PACB

AHCO vs PACB: by the numbers

  • •PACB is the larger company ($839M vs $797M market cap).
  • •Both run net losses; AHCO's is the smaller (-7.58% vs -82.49% net margin).
  • •AHCO grew revenue faster over the past five years (11.68% vs 8.52% CAGR).

Metrics side by side

Valuation

MetricAHCOPACB
P/S ratio0.265.27
P/B ratio0.58N/A
EV / EBITDA6.66N/A
FCF yield12.25%N/A

Profitability

MetricAHCOPACB
Gross margin10.37%35.97%
Operating margin-0.31%-348.46%
Net margin-7.58%-82.49%
ROE-16.56%N/A
ROIC-0.26%-23.80%

Growth (annualized)

MetricAHCOPACB
Revenue CAGR (5Y)11.68%8.52%
FCF CAGR (5Y)7.07%N/A
Total return CAGR (5Y)-24.65%-35.20%

Frequently asked

Which has grown faster, AHCO or PACB?
Over the past five years, AHCO grew revenue faster — AHCO at a 11.68% CAGR versus PACB at 8.52%.
How have AHCO and PACB total returns compared?
Over the past 5 years, AHCO delivered -24.65% and PACB delivered -35.20% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.